CD19 positive cancers include diseases with high-priority medical needs such as r/r B-cell acute lymphoblastic leukemia (B-ALL), B-cell chronic lymphocytic leukemia (B-CLL), B-cell Non-Hodgkin lymphoma (B-NHL), and other B-cell malignancies. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.